Cosmo Pharmaceuticals N.V. (VIE:COPN)

Austria flag Austria · Delayed Price · Currency is EUR
136.00
-5.00 (-3.55%)
Last updated: Feb 4, 2026, 11:00 AM CET
100.00%
Market Cap2.17B +97.2%
Revenue (ttm)182.27M -1.7%
Net Income59.99M +1.7%
EPS3.67 +0.1%
Shares Outn/a
PE Ratio36.21
Forward PE465.83
Dividend2.05 (1.63%)
Ex-Dividend DateJun 4, 2025
Volumen/a
Average Volumen/a
Open135.00
Previous Close141.00
Day's Range135.00 - 136.00
52-Week Range44.80 - 141.00
Betan/a
RSI68.54
Earnings DateMar 9, 2026

About Cosmo Pharmaceuticals

Cosmo Pharmaceuticals N.V. focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delive... [Read more]

Industry Pharmaceutical Preparations
Founded 1997
Employees 332
Stock Exchange Vienna Stock Exchange
Ticker Symbol COPN
Full Company Profile

Financial Performance

Financial Statements